Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.56.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.29.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.29.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.10.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BA.2.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.20.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.17.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.562ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.219ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.114ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used